Trytosaveabit commented on a stock · Oct 16, 2023 06:04

WATCHING!

$Bolt Biotherapeutics (BOLT.US)$ Bolt Biotherapeutics to Present New Clinical Data from Completed Phase 1/2 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Solid Tumors at the ESMO Congress 2023

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

2850 Views

Comment

Trytosaveabit

3580Followers

23Following

53KVisitors